Examining the Impact of a 9-Component Bundle and the INICC Multidimensional Approach on Catheter-Associated Urinary Tract Infection Rates in 32 Countries across Asia, Eastern Europe, Latin America, and the Middle East
Abstract
BACKGROUND
Catheter-Associated Urinary Tract Infections (CAUTIs) frequently occur in the ICU and are correlated with a significant burden.
METHODS
We implemented a strategy involving a 9-element bundle, education, surveillance of CAUTI rates and clinical outcomes, monitoring compliance with bundle components, feedback of CAUTI rates and performance feedback. This was executed in 299 ICUs across 32 low- and middle-income countries (LMICs). The dependent variable was CAUTI per 1,000-UC-days, assessed at baseline and throughout the intervention, in the 2nd month, 3rd month, 4-15 months, 16-27 months, and 28-39 months. Comparisons were made using a two-sample t-test, and the exposure-outcome relationship was explored using a generalized linear mixed model with a Poisson distribution.
RESULTS
Over the course of 978,364 patient-days, 150,258 patients utilized 652,053 UC-days. The rates of CAUTI per 1,000 UC-days were measured. The rates decreased from 14.89 during the baseline period to 5.51 in the 2nd month (RR=0.37; 95% CI= 0.34-0.39; P<0.001), 3.79 in the 3rd month (RR=0.25; 95% CI= 0.23-0.28; P<0.001), 2.98 in the 4-15 months (RR=0.21; 95% CI=0.18-0.22; P<0.001), 1.86 in the 16-27 months (RR=0.12; 95% CI=0.11-0.14; P<0.001), and 1.71 in the 28-39 months (RR=0.11; 95% CI=0.09-0.13; P<0.001).
CONCLUSIONS
Our intervention, without substantial costs or additional staffing, achieved an 89% reduction in CAUTI incidence in ICUs across 32 countries, demonstrating feasibility in ICUs…
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.